Rhythm Pharmaceuticals reported revenue of $71.25M and net income of -$50.65M for the quarter ended Jun 2026, up 46.9% year over year. This income statement covers 40 quarters of results from Sep 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||||||||
| Revenue | 1.03M | 1.82M | 1.50M | 9.07M | 4.28M | 8.79M | 11.47M | 19.22M | 22.50M | 24.23M | 25.97M | 29.08M | 33.25M | 41.83M | 32.70M | 48.50M | 51.30M | 57.25M | 60.11M | 71.25M | ||||||||||||||||||||
| Cost of RevenueCost of Rev | 0.22M | 0.24M | 0.23M | 0.38M | 0.50M | 1.03M | 1.42M | 2.24M | 2.41M | 3.23M | 2.81M | 2.95M | 3.83M | 3.79M | 3.65M | 5.54M | 5.50M | 4.80M | 7.16M | 8.93M | ||||||||||||||||||||
| Gross Profit | 0.81M | 1.58M | 1.27M | 8.69M | 3.79M | 7.76M | 10.05M | 16.98M | 20.09M | 21.00M | 23.16M | 26.13M | 29.42M | 38.04M | 29.06M | 42.96M | 45.80M | 52.45M | 52.95M | 62.32M | ||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 27.54M | 31.57M | 32.51M | 31.46M | 21.12M | 23.55M | 37.95M | 33.54M | 33.57M | 29.89M | 128.66M | 30.19M | 37.93M | 41.17M | 36.97M | 42.31M | 46.03M | 42.03M | 41.73M | 43.43M | ||||||||||||||||||||
| Selling, General & AdministrativeSG&A | 17.51M | 21.00M | 21.45M | 22.33M | 21.94M | 26.32M | 24.63M | 30.05M | 30.48M | 32.37M | 34.38M | 36.41M | 35.38M | 38.13M | 39.09M | 45.95M | 52.42M | 57.48M | 63.59M | 67.45M | ||||||||||||||||||||
| Other Operating ExpensesOther Opex | 0.22M | 0.24M | 0.23M | 0.38M | 0.50M | 1.03M | 1.42M | 2.24M | 2.41M | 3.23M | 2.81M | 2.95M | 3.83M | 3.79M | 3.65M | 5.54M | 5.50M | 4.80M | 7.16M | 8.93M | ||||||||||||||||||||
| Operating ExpensesOpex | 45.27M | 52.81M | 54.19M | 54.16M | 43.55M | 50.89M | 64.00M | 65.83M | 66.46M | 65.50M | 165.85M | 69.56M | 77.14M | 83.08M | 79.71M | 93.80M | 103.95M | 104.32M | 112.47M | 119.81M | ||||||||||||||||||||
| Operating IncomeOp. Inc | -44.24M | -50.99M | -52.69M | -45.10M | -39.27M | -42.10M | -52.53M | -46.60M | -43.95M | -41.27M | -139.89M | -40.48M | -43.88M | -41.26M | -47.00M | -45.30M | -52.65M | -47.06M | -52.36M | -48.55M | ||||||||||||||||||||
| EBIT | -44.24M | -50.99M | -52.69M | -45.10M | -39.27M | -42.10M | -52.53M | -46.60M | -43.95M | -41.27M | -139.89M | -40.48M | -43.88M | -41.26M | -47.00M | -45.30M | -52.65M | -47.06M | -52.36M | -48.55M | ||||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.05M | 2.14M | 3.01M | 3.06M | 3.30M | 3.15M | 4.55M | 4.75M | 4.60M | 5.24M | 5.45M | 5.41M | 5.82M | 4.74M | 4.62M | 4.58M | 4.54M | |||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.14M | 0.13M | 0.16M | 0.27M | 0.92M | 3.04M | 3.44M | 3.22M | 3.47M | 3.82M | 3.05M | 4.10M | 4.05M | 3.52M | 3.64M | 3.24M | 4.33M | 4.08M | 3.55M | 3.22M | ||||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.23M | -0.13M | -0.37M | -0.42M | -0.03M | -0.02M | -0.16M | 0.56M | 0.52M | 8.90M | 1.09M | -0.64M | 1.58M | 0.27M | 0.06M | -1.70M | 1.02M | |||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.14M | 0.13M | -0.07M | 0.10M | -1.59M | -0.39M | 0.35M | -0.10M | 0.16M | -0.17M | -1.19M | 8.70M | -0.10M | -2.13M | -2.41M | -1.00M | -0.14M | -0.47M | -2.73M | -0.30M | ||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||||
| EBT | -44.10M | -50.85M | -52.53M | -44.87M | -40.86M | -42.49M | -52.18M | -46.70M | -43.80M | -41.44M | -141.07M | -31.78M | -43.98M | -43.38M | -49.42M | -46.30M | -52.79M | -47.54M | -55.09M | -48.85M | ||||||||||||||||||||
| Tax ProvisionsTaxes | -8.99M | 0.37M | 0.20M | 0.30M | 0.50M | -0.34M | -0.09M | 0.10M | 0.34M | 0.11M | -0.03M | 0.55M | 0.44M | |||||||||||||||||||||||||||
| Profit After TaxPAT | -44.10M | -42.87M | -52.76M | -45.00M | -40.86M | -42.49M | -52.18M | -46.70M | -44.16M | -41.63M | -141.37M | -32.26M | -43.64M | -47.44M | -49.50M | -50.18M | -52.90M | -53.64M | -55.64M | -50.65M | ||||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -35.11M | -50.85M | -52.53M | -44.87M | -40.86M | -42.49M | -52.18M | -46.70M | -44.16M | -41.63M | -141.37M | -32.28M | -43.64M | -43.29M | -49.52M | -46.63M | -52.90M | -47.51M | -55.64M | -49.30M | ||||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -35.11M | -50.85M | -52.53M | -44.87M | -40.86M | -42.49M | -52.18M | -46.70M | -44.16M | -41.63M | -141.37M | -32.28M | -43.64M | -43.29M | -49.52M | -46.63M | -52.90M | -47.51M | -55.64M | -49.30M | ||||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -35.11M | -50.85M | -52.53M | -44.87M | -40.86M | -42.49M | -52.18M | -46.70M | -44.16M | -41.63M | -141.37M | -32.28M | -43.64M | -43.29M | -49.52M | -46.63M | -52.90M | -47.51M | -55.64M | -49.30M | ||||||||||||||||||||
| Preferred Dividend PaymentsPref Dividends | 1.30M | 1.33M | 1.34M | 1.32M | 1.35M | 1.38M | 1.35M | 1.10M | 1.06M | |||||||||||||||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -35.11M | -50.85M | -52.53M | -44.87M | -40.86M | -42.49M | -52.18M | -46.70M | -44.16M | -41.63M | -141.37M | -33.56M | -44.97M | -44.63M | -50.82M | -47.98M | -54.28M | -48.84M | -56.74M | -50.36M | ||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -0.70 | -1.03 | -1.04 | -0.89 | -0.79 | -0.82 | -0.92 | -0.82 | -0.76 | -0.72 | -2.35 | -0.55 | -0.73 | -0.73 | -0.81 | -0.75 | -0.82 | -0.75 | -0.83 | -0.73 | ||||||||||||||||||||
| EPS (Diluted) | -0.70 | -1.03 | -1.04 | -0.89 | -0.79 | -0.82 | -0.92 | -0.82 | -0.76 | -0.72 | -2.35 | -0.55 | -0.73 | -0.73 | -0.81 | -0.75 | -0.82 | -0.75 | -0.83 | -0.73 | ||||||||||||||||||||
| Shares Outstanding | 50.25M | 49.60M | 50.33M | 50.40M | 51.40M | 52.12M | 56.71M | 56.87M | 57.87M | 57.67M | 60.14M | 61.01M | 61.22M | 61.00M | 63.06M | 63.68M | 66.26M | 64.98M | 67.97M | 68.59M | ||||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 50.25M | 49.60M | 50.33M | 50.40M | 51.40M | 52.12M | 56.71M | 56.87M | 57.87M | 57.67M | 60.14M | 61.01M | 61.22M | 61.00M | 63.06M | 63.68M | 66.26M | 64.98M | 67.97M | 68.59M | ||||||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 50.27M | 50.28M | 50.39M | 50.45M | 55.76M | 56.61M | 56.85M | 56.90M | 59.09M | 59.43M | 60.96M | 61.10M | 61.44M | 62.39M | 63.49M | 63.91M | 66.68M | 67.21M | 68.45M | 68.82M | ||||||||||||||||||||
| EBITDA | -44.24M | -50.99M | -52.69M | -45.10M | -39.27M | -42.10M | -52.53M | -46.60M | -43.95M | -41.27M | -139.89M | -40.48M | -43.88M | -41.26M | -47.00M | -45.30M | -52.65M | -47.06M | -52.36M | -48.55M | ||||||||||||||||||||
| Interest ExpensesInt Expense | 0.05M | 2.14M | 3.01M | 3.06M | 3.30M | 3.15M | 4.55M | 4.75M | 4.60M | 5.24M | 5.45M | 5.41M | 5.82M | 4.74M | 4.62M | 4.58M | 4.54M | |||||||||||||||||||||||
| Tax Rate | 20.40% | -0.84% | -0.47% | -0.21% | -1.57% | 0.78% | 0.21% | -0.20% | -0.73% | -0.21% | 0.07% | -0.99% | -0.91% |